MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1071.64%
Quick Ratio
1071.64%
Cash Ratio
121.74%
Debt to Asset Ratio
20.71%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Lease liability, noncurrent
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
38,626
30,309
51,688
37,815
Short-term investments
293,978
236,577
198,522
214,379
Prepaid expenses and other current assets
7,396
6,407
7,539
8,525
Total current assets
340,000
273,293
257,749
260,719
Long-term investments
90,986
0
8,043
24,944
Operating lease right-of-use asset
37,739
38,819
39,888
40,935
Property and equipment, net
67,382
70,023
72,839
75,896
Deposit placed in escrow
0
0
23,479
23,472
Restricted cash
10,292
10,292
10,292
10,292
Other long-term assets
3,692
3,531
3,615
3,513
Total assets
550,091
395,958
415,905
439,771
Accounts payable
5,964
4,933
4,270
3,699
Accrued and other current liabilities
25,763
23,397
28,244
28,134
Total current liabilities
31,727
28,330
32,514
31,833
Lease liability, noncurrent
70,353
72,633
75,045
77,134
Other long-term liabilities
11,836
16,120
15,804
15,475
Total liabilities
113,916
117,083
123,363
124,442
Common stock, 0.001 par value 800,000,000 and 400,000,000 shares authorized as of june30, 2026 and december31, 2025, respectively 345,345,427 and 229,413,523 shares issued and outstanding as of june30, 2026 and december31, 2025, respectively
345
245
229
223
Additional paid-in capital
2,532,341
2,332,129
2,302,753
2,286,770
Accumulated deficit
-2,095,993
-2,053,316
-2,010,709
-1,971,899
Accumulated other comprehensive income (loss)
-518
-183
269
235
Total stockholders equity
436,175
278,875
292,542
315,329
Total liabilities and stockholders equity
550,091
395,958
415,905
439,771
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$293,978K (33.15%↑ Y/Y)Cash and cashequivalents$38,626K (-26.19%↓ Y/Y)Prepaid expenses andother current assets$7,396K (-22.43%↓ Y/Y)Total current assets$340,000K (20.29%↑ Y/Y)Long-term investments$90,986K (208.32%↑ Y/Y)Property and equipment,net$67,382K (-14.55%↓ Y/Y)Operating leaseright-of-use asset$37,739K (-10.07%↓ Y/Y)Restricted cash$10,292K (0.00%↑ Y/Y)Other long-termassets$3,692K (-3.55%↓ Y/Y)Total assets$550,091K (16.89%↑ Y/Y)Total liabilities andstockholders equity$550,091K (16.89%↑ Y/Y)Total stockholdersequity$436,175K (26.59%↑ Y/Y)Total liabilities$113,916K (-9.61%↓ Y/Y)Accumulated deficit-$2,095,993K (-8.57%↓ Y/Y)Accumulated othercomprehensive income (loss)-$518K (-1051.11%↓ Y/Y)Additional paid-in capital$2,532,341K (11.32%↑ Y/Y)Lease liability,noncurrent$70,353K (-11.22%↓ Y/Y)Total currentliabilities$31,727K (0.16%↑ Y/Y)Other long-termliabilities$11,836K (-21.70%↓ Y/Y)Common stock, 0.001 parvalue 800,000,000 and...$345K (56.82%↑ Y/Y)Accrued and othercurrent liabilities$25,763K (-3.96%↓ Y/Y)Accounts payable$5,964K (22.94%↑ Y/Y)

Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics, Inc. (ALLO)